Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Opioid Maintenance Therapy Linked to Lower Hepatitis C Rates for People Who Inject Drugs

Young drug injectors who undergo opioid agonist maintenance therapy using buprenorphine or methadone have a lower likelihood of becoming infected with hepatitis C virus (HCV) than those who continue injecting or use other types of substance use treatment, according to a study published in the October 27 edition of JAMA Internal Medicine.

Published
29 October 2014
From
HIVandhepatitis.com
Australia's rejection of costly new treatment sofosbuvir a 'death sentence for for Hepatitis C sufferers'

Dr Miriam Levy, the director of gastroenterology at Sydney's Liverpool Hospital, told the conference on Thursday that the recent decision by the Pharmaceutical Benefits Advisory Committee (PBAC) to refuse subsidies for a breakthrough treatment for Hepatitis C had effectively delivered a death sentence to up to 50,000 Australians who would die from the disease in the next few years.

Published
27 October 2014
From
ABC Online
AbbVie 3D HCV regimen well-tolerated in PEARL trials

AbbVie's 3D hepatitis C regimen containing paritaprevir (ABT-450), ombitasvir, and dasabuvir was generally well-tolerated in the Phase 3 PEARL trials, according to a pooled analysis presented at IDWeek

Published
24 October 2014
By
Liz Highleyman
Ireland: Hepatitis C drug to be made available

Minister for Health Leo Varadkar is to make available potentially life-saving treatments for hepatitis C – provided agreement on price can be reached with the manufacturers.

Published
22 October 2014
From
The Irish Times
Advocates Criticize Plans to Restrict N.Y. Hepatitis C Drugs

Advocates argue that the proposed criteria are dangerous for people living with the deadly liver disease.

Published
22 October 2014
From
Poz magazine news
Sofosbuvir/ledipasvir safe and effective for genotype 1 HCV

A single-tablet regimen containing the hepatitis C virus (HCV) nucleotide polymerase inhibitor sofosbuvir and the NS5A inhibitor ledipasvir – the combination in Gilead Science's recently approved Harvoni pill – was well-tolerated and cured 97% of patients with HCV genotype 1 in

Published
20 October 2014
By
Liz Highleyman
HCV sexual transmission: HIV negative may be at risk, more awareness and testing needed

Hepatitis C virus (HCV) is known to be sexually transmitted among HIV positive men who have sex with men, but HIV negative men may be at risk as well, according to recent reports. Other recent studies have looked at awareness of HCV sexual transmission and screening practices, suggesting that improvement is needed in both areas.

Published
16 October 2014
From
HIVandHepatitis.com
Coffee, Even Decaf, May Promote Liver Health

Drinking coffee, whether decaffeinated or regular, is linked to healthier levels on tests indicating liver function.

Published
16 October 2014
From
AIDSMeds
IDWeek 2014: AbbVie 3D HCV Regimen Well-tolerated in PEARL Trials

AbbVie's 3D hepatitis C regimen containing paritaprevir (ABT-450), ombitasvir, and dasabuvir was generally well-tolerated in the Phase 3 PEARL trials, according to a pooled analysis presented at IDWeek 2014 last week in Philadelphia. Serious side effects were uncommon and few people discontinued treatment for this reason.

Published
16 October 2014
From
HIVandHepatitis.com
Unique 'pay if you clear' proposal for new hepatitis drug

The NHS in Scotland could be reimbursed for the cost of a new hepatitis drug if sufferers fail to clear the virus. The novel proposal was revealed after the drug Olysio was cleared for use by the Scottish Medicines Consortium (SMC).

Published
15 October 2014
From
BBC
← First12345...145Next →

Filter by country